S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 98

Issue Date	Title / Author(s) / Citation	File
1998-08	Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: Loss of growth sensitivity but conserved transcriptional response to TGF-beta Kang, Shin H.; Won, Kyungshick; Chung, Hwan‐Wook; Jong, Hyun‐Soon; Song, Yong‐Sang; Kim, Seong‐Jin; Bang, Yung‐Jue; Kim, Noe K. International Journal of Cancer, Vol.77 No.4, pp.620-625	DOI
1999-10	Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma Kim, Noe Kyeong; Im, Seock-Ah; Kim, Dong-Wam; Lee, Moon H.; Jung, Chul W.; Cho, Eun K.; Lee, Jong T.; Ahn, Jin S.; Heo, Dae S.; Bang, Yung-Jue Cancer, Vol.86 No.7, pp.1109-1115	DOI
2001-04	A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies Kim, Noe Kyeong; Kim, Tae‐You; Shin, Sang‐Goo; Park, Young Iee; Lee, Jung Ae; Cho, Yong‐Baik; Kim, Key H.; Kim, Dae‐Kee; Heo, Dae Seog; Bang, Yung‐Jue Cancer, Vol.91 No.8, pp.1549-1556	DOI
2004-01	Suppurative gastritis in BALB/c mice infected with Listetia monocytogenes via the intragastric route Park, JH; Park, YH; Seok, SH; Cho, SA; Kim, DJ; Lee, HY; Kim, SH; Park, JH Journal of Comparative Pathology, Vol.130 No.2-3, pp.130-136	DOI
2004-08	Characteristics of the gastritis induced by Listeria monocytogenes in mice: microbiology, histopathology, and mRNA expression of inflammatory mediators with time course of infection Park, JH; Kim, DJ; Park, YH; Seok, SH; Cho, SA; Baek, MW; Lee, HY; Park, JH Microbial Pathogenesis, Vol.37 No.2, pp.87-94	DOI
2004-10	Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae Kang, CI; Kim, SH; Kim, DM; Park, WB; Lee, KD; Kim, HB; Oh, MD; Min, EC; Choe, KW Infection Control and Hospital Epidemiology, Vol.25 No.10, pp.860-867	DOI
2004-10	Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae Pai, H; Kang, CI; Byeon, JH; Lee, KD; Park, WB; Kim, HB; Kim, EC; Oh, MD; Choe, KW Antimicrobial Agents and Chemotherapy, Vol.48 No.10, pp.3720-3728	DOI
2006-04	Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation Han, Sae-Won; Kim, Tae-You; Jeon, Young Kyung; Hwang, Pil Gyu; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Dong-Wan; Heo, Dae-Seog; Kim, Noe Kyeong; Chung, Doo Hyun; Bang, Yung-Jue Clinical Cancer Research, Vol.12 No.8, pp.2538-2544	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	view file DOI
2009-07	Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study Lee, Kyung Hee; Kim, Min Kyoung; Kim, Yeol Hong; Ryoo, Baek Yeol; Lim, Ho Yeong; Song, Hong Suk; Kim, Hoon Kyo; Lee, Myung Ah; Im, Seock Ah; Chang, Heung Moon; Cho, Jae Yong; Zang, Dae Young; Kim, Bong Seog; Kim, Jun Suk Cancer Chemotherapy and Pharmacology, Vol.64 No.2, pp.317-325	DOI
2009-07	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Soo; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.1, pp.80-84	DOI
2009-08	Expression of P-glycoprotein and Apoptosis in Diffuse Large B-cell Lymphoma Kim, Ji Eun; Kim, Young A.; Chang, Mee Soo; Jeon, Yunkyeong; Paik, JinHo; Yoon, Seon-Og Korean Journal of Pathology, Vol.43 No.4, pp.317-320	DOI
2009-08	Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma Sim, Sung Hoon; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Tae-You; Lee, Jong Seok; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.2, pp.204-207	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2010-03	Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer Koh, Youngil; Jang, Bogun; Han, Sae-Won; Kim, Tae-Min; Oh, Do-Youn; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Kim, Young-Whan; Kim, Joo Hyun; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.5 No.3, pp.320-325	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2010-06	The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer Sun, Jong-Mu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.68 No.3, pp.427-432	DOI
2011-03	Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Hur, Hyung-Seok; Song, Sang-Hyun; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.302 No.2, pp.155-165	DOI
2011-05	Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification Ou, Sai-Hong Ignatius; Kwak, Eunice L.; Siwak-Tapp, Christina; Dy, Joni; Bergethon, Kristin; Clark, Jeffrey W.; Camidge, D. Ross; Solomon, Benjamin J.; Maki, Robert G.; Bang, Yung-Jue; Kim, Dong-Wan; Christensen, James; Tan, Weiwei; Wilner, Keith D.; Salgia, Ravi; Iafrate, A. John Journal of Thoracic Oncology, Vol.6 No.5, pp.942-946	DOI
2012-06	Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150	DOI
2012-07	Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer Kim, Jisun; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Shin, Hee-Chul; You, Jee-Man; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Koo, Hye Ryoung; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Noh, Dong-Young Breast Cancer Research, Vol.14 No.4, p. R102	view file DOI
2012-08	Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon-Kyung; Chung, Doo Hyun; Yang, Seok-Chul; Kim, Young Tae; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.77 No.2, pp.460-463	DOI
2012-10	Treatment of ALK-Positive Non-Small Cell Lung Cancer Bang, Yung-Jue Archives of Pathology and Laboratory Medicine, Vol.136 No.10, pp.1201-1204	DOI
2012-10	Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea Jung, Younghee; Lee, Myung Jin; Sin, Hye-Yun; Kim, Nak-Hyun; Hwang, Jeong-Hwan; Park, Jinyong; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Eu Suk; Park, Sang-Won; Park, Kyoung Un; Kim, Hong Bin; Kim, Nam-Joong; Kim, Eui-Chong; Song, Kyoung-Ho; Oh, Myoung-Don BMC Infectious Diseases, Vol.12, p. 239	DOI
2012-12	Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial de Gramont, Aimery; Van Cutsem, Eric; Schmoll, Hans-Joachim; Tabernero, Josep; Clarke, Stephen; Moore, Malcolm J.; Cunningham, David; Cartwright, Thomas H.; Hecht, J. Randolph; Rivera, Fernando; Im, Seock-Ah; Bodoky, Gyoergy; Salazar, Ramon; Maindrault-Goebel, Frederique; Shacham-Shmueli, Einat; Bajetta, Emilio; Makrutzki, Martina; Shang, Aijing; Andre, Thierry; Hoff, Paulo M. The Lancet Oncology, Vol.13 No.12, pp.1225-1233	DOI
2012-12	Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group Park, S. H.; Ryu, M. H.; Ryoo, B. Y.; Im, S. A.; Kwon, H. C.; Lee, S. S.; Park, S. R.; Kang, B. Y.; Kang, Y. K. Investigational New Drugs, Vol.30 No.6, pp.2377-2383	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-08	Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? a retrospective case-control study Kang, Chang Kyung; Kim, Eu Suk; Song, Kyoung-Ho; Kim, Hong Bin; Kim, Taek Soo; Kim, Nak-Hyun; Kim, Chung-Jong; Choe, Pyoeng Gyun; Bang, Ji-Hwan; Park, Wan Beom; Park, Kyoung Un; Park, Sang Won; Kim, Nam-Joong; Kim, Eui-Chong; Oh, Myoung-don BMC Infectious Diseases, Vol.13 No.1, p. 365	DOI
2014-04	Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact Sohn, Hojoon; Aero, Abebech D.; Menzies, Dick; Behr, Marcel; Schwartzman, Kevin; Alvarez, Gonzalo G.; Dan, Andrei; McIntosh, Fiona; Pai, Madhukar; Denkinger, Claudia M. CLINICAL INFECTIOUS DISEASES, Vol.58 No.7, pp.970-976	DOI
2014-11	Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive, First-Line Metastatic Breast Cancer Baselga, Jose; Cortes, Javier; Im, Seock-Ah; Clark, Emma; Ross, Graham; Kiermaier, Astrid; Swain, Sandra M. Journal of Clinical Oncology, Vol.32 No.33, pp.3753-3761	DOI
2014-12	Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial Jaenne, Pasi A.; Ou, Sai-Hong I.; Kim, Dong-Wan; Oxnard, Geoffrey R.; Martins, Renato; Kris, Mark G.; Dunphy, Frank; Nishio, Makoto; O'Connell, Joseph; Paweletz, Cloud; Taylor, Ian; Zhang, Hui; Goldberg, Zelanna; Mok, Tony The Lancet Oncology, Vol.15 No.13, pp.1433-1441	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2015-01	Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer Lee, H. J.; Seo, A. N.; Kim, E. J.; Jang, M. H.; Kim, Y. J.; Kim, J. H.; Kim, S. -W.; Ryu, H. S.; Park, I. A.; Im, S. -A.; Gong, G.; Jung, K. H.; Kim, H. J.; Park, S. Y. British Journal of Cancer, Vol.112 No.1, pp.103-111	DOI
2015-01	In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Anticancer Research, Vol.35 No.1, pp.175-182
2015-02	Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor Won, J. K.; Keam, B.; Koh, J.; Cho, H. J.; Jeon, Y. K.; Kim, T. M.; Lee, S. H.; Lee, D. S.; Kim, D. W.; Chung, D. H. Annals of Oncology, Vol.26 No.2, pp.348-354	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Bang, Yung-Jue Breast Cancer Research, Vol.17, p. 33	view file DOI
2015-11	Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure Cho, Kyoung Min; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.30 No.6, pp.891-898	view file DOI
2015-11	Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells Oh, Se Jin; Noh, Kyung Hee; Lee, Young-Ho; Hong, Soon-Oh; Song, Kwon-Ho; Lee, Hyo-Jung; Kim, Soyeon; Kim, Tae Min; Jeon, Ju-Hong; Seo, Jae Hong; Kim, Dong-Wan; Kim, Tae Woo Oncotarget, Vol.6 No.37, pp.40255-40267	view file DOI
2015-12	MET amplification, protein expression, and mutations in pulmonary adenocarcinoma Park, Seongyeol; Koh, Jaemoon; Kim, Dong-Wan; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.90 No.3, pp.381-387	DOI
2016-03	Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study Ou, Sai-Hong Ignatius; Ahn, Jin Seok; De Petris, Luigi; Govindan, Ramaswamy; Yang, James Chih-Hsin; Hughes, Brett; Lena, Herve; Moro-Sibilot, Denis; Bearz, Alessandra; Ramirez, Santiago Viteri; Mekhail, Tarek; Spira, Alexander; Bordogna, Walter; Balas, Bogdana; Morcos, Peter N.; Monnet, Annabelle; Zeaiter, Ali; Kim, Dong-Wan Journal of Clinical Oncology, Vol.34 No.7, pp.661-668	DOI

1 2 3